SPITFIRE PHARMA
Spitfire Pharma, Inc. offers drug development and research services to improve the pharmaceutical properties of peptide drugs. The company was founded in 2011 and is based in South San Francisco, California.
SPITFIRE PHARMA
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
2011-01-01
Address:
South San Francisco, California, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
500 K USD
Similar Organizations
CiVi Biopharma
CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.
Harris Pharmaceutical
Harris Pharmaceutical offers product development, training, manufacturing, and marketing of a wide range of generic drugs.
Picket pharmaceuticals
Picket pharmaceuticals develops and brings to market innovative complex generic pharmaceutical products across a range of therapeutic areas.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Founder
Investors List
CMEA Capital
CMEA Capital investment in Venture Round - Spitfire Pharma
More informations about "Spitfire Pharma"
Spitfire Pharma 2025 Company Profile: Valuation, …
Spitfire Pharma General Information Description. Developer of peptide drugs designed for the treatment of diabetes and obesity. The company's drugs offer drug development and research services for the development of SP-1373 …See details»
Acquisition of Spitfire Pharma Inc. - Altimmune
Business matters, including without limitation, the closing of the Spitfire Pharma acquisition, the timing of key milestones for ALT-801, the filing of the IND for ALT-801 in 2020, the initiation of …See details»
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, …
Jul 9, 2019 Any statements made in this press release relating to future financial or business performance, conditions, plans, prospects, trends, or strategies and other financial and …See details»
EX-2.1 - SEC.gov
Exhibit 2.1 . STRICTLY CONFIDENTIAL . Execution Version . AGREEMENT AND PLAN OF MERGER AND REORGANIZATION. BY AND AMONG . ALTIMMUNE, INC., . SPRINGFIELD …See details»
Altimmune acquires Spitfire Pharma - NLS - Nordic Life Science
Jul 5, 2019 The company announced earlier this summer that it has entered into an agreement to acquire Spitfire Pharma, Inc. (Spitfire) including its product candidate SP-1373 (to be …See details»
Altimmune acquires Spitfire Pharma | Drug Discovery News
Jul 10, 2019 Spitfire, a portfolio company of Presidio Partners, was founded by John J. Nestor, Jr., Ph.D. and Velocity Pharmaceutical Development LLC, for the sole purpose of developing …See details»
Spitfire Pharma - Funding, Financials, Valuation & Investors
Spitfire Pharma offers drug development and research services that improve the pharmaceutical properties of peptide drugs.See details»
Spitfire Pharma, LLC Company Profile - Dun & Bradstreet
Pharmaceutical and Medicine Manufacturing Chemical Manufacturing Manufacturing Printer Friendly View Address: 910 Clopper Rd Ste 201S Gaithersburg, MD, 20878-1361 United StatesSee details»
Spitfire Pharma, Inc. - Drug pipelines, Patents, Clinical trials
Explore Spitfire Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
Spitfire Pharma - Products, Competitors, Financials, Employees ...
Jul-2019: Altimmune took over Spitfire Pharma, a California drug developer. Under this acquisition, Spitfire’s flagship product, a treatment for nonalcoholic steatohepatitis, or NASH, a …See details»
Spitfire Pharma LLC | TREA
Spitfire Pharma LLC Sarah K. Browne A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE Information Patent Application. GLP-1R, GIP-R AND/OR GCGR AGONISTS, …See details»
Altimmune, Inc. completed the acquisition of Spitfire Pharma, Inc.
Jul 11, 2019 Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. The Company's lead product candidate, …See details»
Spitfire Pharma - Updates, News, Events, Signals & Triggers
Spitfire Pharma offers drug development and research services that improve the pharmaceutical properties of peptide drugs.See details»
Altimmune to buy Presidio Partners portfolio firm Spitfire Pharma
Under the deal, Spitfire shareholders will secure an upfront payment of $5m (£4m) in Altimmune common stock, as well as up to additional $8m (£6.4m) in future regulatory and clinical …See details»
Altimmune to acquire Spitfire Pharma for up to $93M
Jul 9, 2019 Maryland biotech Altimmune Inc. has reached an agreement to acquire California drug developer Spitfire Pharma Inc. in a move that sent the local company’s stock …See details»
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, …
Jul 9, 2019 GAITHERSBURG, MD, USA I July 09, 2019 I Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has entered into an …See details»
SPITFIRE PHARMA, INC. - US Patent and Trademark Search
Spitfire Pharma, Inc. of DELAWARE uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and …See details»
Spitfire Pharma - Tech Stack, Apps, Patents & Trademarks
Spitfire Pharma offers drug development and research services that improve the pharmaceutical properties of peptide drugs. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Spitfire Pharma, Inc. will present body weight, liver weight and ...
Apr 11, 2017 About Spitfire Pharma, Inc. Spitfire Pharma, Inc., is a "virtual" company which was created to hold the ownership of the SP-1373 development program. Spitfire is funded by …See details»
Simplification for success: Rewiring the biopharma operating model
6 days ago Pharma companies should identify the capabilities that are essential for their future portfolios and differentiate between areas where they must excel and those where industry …See details»